Halozyme Announces Preclinical Data Presentations At The Association Of ... MarketWatch The first presentation includes preclinical data showing that treatment of tumors with PEGPH20 enhances the action of immune-based cancer therapy such as monoclonal antibodies (mAbs). The second presentation includes preclinical data showing that ... |
